Q1 2025 Earnings Call Transcript February 13, 2025 Applied DNA Sciences, Inc. misses on earnings expectations. Reported EPS is $-0.56 EPS, expectations were $-0.32. Operator: Good day, and welcome to ...
In a study published in Nature Structural and Molecular Biology, scientists from the Department of Medical Biochemistry and ...
Researchers have created a novel imaging-technology combination that can capture gene activity in individual bacteria in ...
Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...
Applied DNA Sciences Inc (NASDAQ:APDN) reported its financial results for the first quarter of fiscal year 2025, showcasing a notable increase in revenue but also highlighting ongoing challenges with ...
Cancer cells have special adaptation mechanisms that allow them to proliferate despite changes in their genetic makeup.
According to the World Health Organization (WHO), hundreds of millions of new cases of bacterial sexually transmitted ...
Innovative Takumi-shaped DNA hydrogels exhibit prolonged retention and drug release, showcasing their potential as biocompatible delivery systems in medicine.
Hydrogels are polymeric materials with three-dimensional network structures containing large amounts of water. They serve as sustained-release drug delivery systems as they can encapsulate various ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results